Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
99 hedge funds and large institutions have $1.05B invested in Silk Road Medical, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 99 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Warburg Pincus
New York
|
+$519M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.6M |
| 3 |
DM
Deerfield Management
New York
|
+$21.2M |
| 4 |
Jennison Associates
New York
|
+$18.1M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$16.5M |
Top Sellers
SILK Hedge Fund Activity: Q2 2019 in Review
99 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q2 2019, worth a combined $1.05B.
Buyers outnumbered sellers: 99 funds opened new SILK positions and 0 closed out — a net gain of 99 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Warburg Pincus, opening a new position worth an estimated $519M.
- 99 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q2 2019, up from 0 in Q1 2019.
- Funds reported $1.05B of Silk Road Medical, Inc. Common Stock stock for Q2 2019.
- 99 funds opened new Silk Road Medical, Inc. Common Stock positions in Q2 2019 and 0 closed out, a net change of +99 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q2 2019 was Warburg Pincus, an estimated $519M added.
Based on aggregated 13F filings for Q2 2019.